Viewing StudyNCT00094822



Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00094822
Status: COMPLETED
Last Update Posted: 2009-02-13
First Post: 2004-10-27

Brief Title: Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer NSCLC
Sponsor: Amgen
Organization: Amgen

Organization Data

Organization: Amgen
Class: INDUSTRY
Study ID: 20030123
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Amgen
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Global Development Leader
Old Organization: Amgen Inc

Collaborators